- Home
- SEGG vs QNRX Comparison
SEGG vs QNRX Comparison
Compare SEGG & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SEGG | QNRX |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | 12 | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.4M | 14.5M |
| IPO Year | 2023 | 2023 |
Fundamental Metrics
Financial Performance| Metric | SEGG | QNRX |
|---|---|---|
| Price | $0.63 | $5.65 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 34.0K |
| Earning Date | 05-20-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $5.32 |
| 52 Week High | $7.61 | $41.80 |
Technical Indicators
Market Signals| Indicator | SEGG | QNRX |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 36.36 |
| Support Level | $0.48 | $5.47 |
| Resistance Level | $0.80 | $6.98 |
| Average True Range (ATR) | 0.08 | 0.52 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 47.72 | 19.88 |
Price Performance
Historical ComparisonAbout SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a sports, entertainment and gaming group operating digital assets such as Sports.com and Lottery.com. It is focused on immersive fan engagement, ethical gaming and AI-driven live experiences.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.